Once weekly thyroxine treatment as a strategy to treat non‐compliance

AUTOR(ES)

Rangan, S

FONTE

BMJ Group

RESUMO

Hypothyroidism is a common disorder, which is mainly treated in primary rather than secondary care. Once daily thyroxine replacement restores euthyroidism in most patients; some patients, however, remain hypothyroid despite adequate thyroxine replacement. Non‐compliance is the most common cause of lack of response to thyroxine treatment. We describe two cases of primary hypothyroidism in which daily thyroxine treatment did not restore biochemical euthyroidism but once weekly thyroxine treatment was successful. In addition we review the evidence and discuss the differential diagnosis of lack of response to thyroxine treatment. Once weekly thyroxine treatment can be a safe, well‐tolerated, and effective therapy for patients with non‐compliance.

Documentos Relacionados

• Patient non-compliance with paper diaries
• Determinants of non-compliance with short term antibiotic regimens.
• A study of the causes of non-compliance by patients prescribed eyedrops.
• Transcription Attenuation: Once Viewed as a Novel Regulatory Strategy
• Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children.